Syringe Market

Future Prospects and Market Overview of the Syringe Market

by

The Syringe Market is estimated to be valued at US$ 14,839.3 Mn in 2021 and is expected to reach a market value of US$ (incorporate given market value for 2022) Bn or Mn by 2022. With a projected CAGR of 8.0% over the forecast period (2022-2028), the market is set to experience significant growth. This market report, published by Coherent Market Insights, provides a comprehensive analysis of the market dynamics and future prospects.

Market Overview:
The Syringe Market comprises a wide range of products used in the healthcare industry. These products are used for various purposes, such as administering drugs, blood collection, and intravenous feeding. Syringes are essential medical devices that play a crucial role in delivering accurate dosages of medication to patients. The market is driven by the increasing prevalence of chronic diseases, the growing demand for vaccines and injectable drugs, and advancements in syringe technology. There is a constant need for sterile and safe syringes in healthcare settings, which fuels the demand for syringe products.

Market Dynamics:
The Syringe Market is primarily driven by two key factors. Firstly, the rise in chronic diseases, such as diabetes and cancer, has significantly increased the demand for syringe products. These diseases require regular medication and injections, thereby driving the market growth. Secondly, the growing emphasis on vaccination programs and immunization campaigns globally has boosted the demand for syringes. Governments and organizations worldwide are focusing on preventing the spread of infectious diseases through vaccination, which further propels the market growth. Overall, the Syringe Market is expected to witness substantial growth in the coming years due to these driving factors.
Market Key Trends:

The key trend in the syringe market is the increasing demand for self-administration of injectable medications. With the growing prevalence of chronic diseases and the rise in the aging population, there is a rising need for patients to self-administer their medications at home. This trend is driven by factors such as convenience, cost-effectiveness, and improved patient empowerment. Self-administration of injectable medications through syringes allows patients to have better control over their treatment plans and reduces healthcare expenses associated with hospital visits for medication administration. Additionally, advancements in technology have led to the development of user-friendly and safe self-injection devices, further fueling the demand for syringes in the market.

SWOT Analysis:

Strength: The syringe market benefits from the increasing prevalence of chronic diseases and the rise in the aging population, which drives the demand for injectable medications. This creates a steady and growing market opportunity for syringe manufacturers.

Weakness: The syringe market faces challenges such as the availability of alternative drug delivery methods, such as autoinjectors and pen injectors, which may reduce the demand for traditional syringes. Additionally, concerns regarding needlestick injuries and the improper disposal of syringes can impact market growth.

Opportunity: Growing healthcare infrastructure in emerging economies presents an opportunity for syringe manufacturers to tap into new markets. Additionally, the development of innovative and user-friendly syringes with features such as safety mechanisms and integrated technologies can help the market gain a competitive edge.

Threats: The syringe market faces threats from stringent regulations regarding the manufacturing and disposal of syringes. Additionally, the presence of counterfeit syringes in the market poses a risk to patient safety and can damage the reputation of legitimate syringe manufacturers.

Key Takeaways:

The global syringe market Share is expected to witness high growth, exhibiting a CAGR of 8.0% over the forecast period (2022-2028). This growth is driven by the increasing demand for self-administration of injectable medications, particularly for chronic diseases. The market size for 2021 was valued at US$ 14,839.3 Mn.

In terms of regional analysis, Asia Pacific is expected to be the fastest-growing and dominating region in the syringe market. The region’s large population, increasing prevalence of chronic diseases, and improving healthcare infrastructure contribute to the high demand for syringes.

Key players operating in the syringe market include Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Codan Medizinische Geräte GmbH & Co. KG, and Hindustan Syringes & Medical Devices Limited. These players are actively involved in product innovation, mergers and acquisitions, and strategic collaborations to maintain their market position and cater to the growing demand for syringes.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it